- Home
- ASYS vs APLT Comparison
ASYS vs APLT Comparison
Compare ASYS & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- APLT
- Stock Information
- Founded
- ASYS 1981
- APLT 2016
- Country
- ASYS United States
- APLT United States
- Employees
- ASYS N/A
- APLT N/A
- Industry
- ASYS Industrial Machinery/Components
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- APLT Health Care
- Exchange
- ASYS Nasdaq
- APLT Nasdaq
- Market Cap
- ASYS 68.0M
- APLT 69.0M
- IPO Year
- ASYS N/A
- APLT 2019
- Fundamental
- Price
- ASYS $6.02
- APLT $0.51
- Analyst Decision
- ASYS
- APLT Buy
- Analyst Count
- ASYS 0
- APLT 6
- Target Price
- ASYS N/A
- APLT $6.10
- AVG Volume (30 Days)
- ASYS 63.8K
- APLT 893.4K
- Earning Date
- ASYS 08-06-2025
- APLT 08-13-2025
- Dividend Yield
- ASYS N/A
- APLT N/A
- EPS Growth
- ASYS N/A
- APLT N/A
- EPS
- ASYS N/A
- APLT N/A
- Revenue
- ASYS $83,634,000.00
- APLT $121,000.00
- Revenue This Year
- ASYS N/A
- APLT $415.60
- Revenue Next Year
- ASYS $12.93
- APLT $1,323.96
- P/E Ratio
- ASYS N/A
- APLT N/A
- Revenue Growth
- ASYS N/A
- APLT N/A
- 52 Week Low
- ASYS $3.20
- APLT $0.30
- 52 Week High
- ASYS $6.81
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- ASYS 64.91
- APLT 61.88
- Support Level
- ASYS $5.40
- APLT $0.47
- Resistance Level
- ASYS $5.13
- APLT $0.53
- Average True Range (ATR)
- ASYS 0.41
- APLT 0.03
- MACD
- ASYS 0.10
- APLT 0.00
- Stochastic Oscillator
- ASYS 90.80
- APLT 83.33
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.